Dr Joseph Singh, MD - Medicare Nephrology in Hartford, CT

Dr Joseph Singh, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Hartford, Connecticut. He went to Northeastern Ohio University College Of Medicine and graduated in 2004 and has 20 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Hartford Hospital, Starling Physicians, Pllc and his current practice location is 85 Seymour St, Suite 900, Hartford, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 241-0700.

Dr Joseph Singh is licensed to practice in Connecticut (license number 050192) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801016258.

Contact Information

Dr Joseph Singh, MD
85 Seymour St, Suite 900,
Hartford, CT 06106-5501
(860) 241-0700
(860) 525-7881



Physician's Profile

Full NameDr Joseph Singh
GenderMale
SpecialityNephrology
Experience20 Years
Location85 Seymour St, Hartford, Connecticut
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Joseph Singh attended and graduated from Northeastern Ohio University College Of Medicine in 2004
  NPI Data:
  • NPI Number: 1801016258
  • Provider Enumeration Date: 04/26/2007
  • Last Update Date: 03/07/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3870689367
  • Enrollment ID: I20110819000179

Medical Identifiers

Medical identifiers for Dr Joseph Singh such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1801016258NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 050192 (Connecticut)Primary
207R00000XInternal Medicine 050192 (Connecticut)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Palomba Drive DialysisEnfield, CTDialysis facility
Hartford HospitalHartford, CTHospital
Middlesex HospitalMiddletown, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Hartford Hospital2567366016827
Starling Physicians, Pllc7517863749204

News Archive

Researchers develop new mouse model of VUR to study chronic kidney disease in children

Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children. Doctors and researchers at Nationwide Children's Hospital have developed a new mouse model of vesicoureteral reflux, a common childhood condition that can lead to chronic kidney disease in children.

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

TriVascular treats first Canadian patients with Ovation Abdominal Stent Graft

TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

Biovest targets mantle cell lymphoma as next indication for BiovaxID

Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Joseph Singh allows following entities to bill medicare on his behalf.
Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407806391
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000700

News Archive

Researchers develop new mouse model of VUR to study chronic kidney disease in children

Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children. Doctors and researchers at Nationwide Children's Hospital have developed a new mouse model of vesicoureteral reflux, a common childhood condition that can lead to chronic kidney disease in children.

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

TriVascular treats first Canadian patients with Ovation Abdominal Stent Graft

TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

Biovest targets mantle cell lymphoma as next indication for BiovaxID

Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.

Read more Medical News

› Verified 5 days ago

Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770696643
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000752

News Archive

Researchers develop new mouse model of VUR to study chronic kidney disease in children

Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children. Doctors and researchers at Nationwide Children's Hospital have developed a new mouse model of vesicoureteral reflux, a common childhood condition that can lead to chronic kidney disease in children.

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

TriVascular treats first Canadian patients with Ovation Abdominal Stent Graft

TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

Biovest targets mantle cell lymphoma as next indication for BiovaxID

Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.

Read more Medical News

› Verified 5 days ago

Entity NameStarling Physicians, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467537290
PECOS PAC ID: 7517863749
Enrollment ID: O20031209000877

News Archive

Researchers develop new mouse model of VUR to study chronic kidney disease in children

Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children. Doctors and researchers at Nationwide Children's Hospital have developed a new mouse model of vesicoureteral reflux, a common childhood condition that can lead to chronic kidney disease in children.

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

TriVascular treats first Canadian patients with Ovation Abdominal Stent Graft

TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

Biovest targets mantle cell lymphoma as next indication for BiovaxID

Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Joseph Singh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Joseph Singh, MD
2110 Silas Deane Hwy,
Rocky Hill, CT 06067-2313

Ph: (860) 258-3480
Dr Joseph Singh, MD
85 Seymour St, Suite 900,
Hartford, CT 06106-5501

Ph: (860) 241-0700

News Archive

Researchers develop new mouse model of VUR to study chronic kidney disease in children

Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children. Doctors and researchers at Nationwide Children's Hospital have developed a new mouse model of vesicoureteral reflux, a common childhood condition that can lead to chronic kidney disease in children.

Stereotactic body radiation therapy safe and effective way to treat early stage lung cancer in medically inoperable patients

Lung cancer patients with extenuating health problems may have an alternative to traditional radiation therapy through a lung-sparing procedure pioneered at the Indiana University School of Medicine.

TriVascular treats first Canadian patients with Ovation Abdominal Stent Graft

TriVascular, Inc. of Santa Rosa, California, announced today the first Canadian patients treated with its Ovation Abdominal Stent Graft. The innovative, ultra low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy.

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

Biovest targets mantle cell lymphoma as next indication for BiovaxID

Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.

Read more News

› Verified 5 days ago


Internal Medicine Doctors in Hartford, CT

Gagandeep Singh, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Hartford, CT 06105
Phone: 860-714-7446    Fax: 860-714-1508
Yixia Ye, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 31 Seymour St Ste 205, Hartford, CT 06106
Phone: 860-524-2610    
Andrew P Scatola, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 85 Jefferson Street, Hartford Hospital Cardiology Dept, Hartford, CT 06106
Phone: 860-972-1212    
Dr. David Jay Altszuler, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 85 Seymour St Ste 719, Hartford, CT 06106
Phone: 860-522-0604    Fax: 860-522-0604
Dr. Nisha Dhanabalsamy, MBBS
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 80 Seymour St, Hartford, CT 06102
Phone: 860-972-0549    
Sindhuja Palle, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 80 Seymour St, Hartford, CT 06106
Phone: 860-545-5000    
Dr. Jamie Matthew Roche, M.D.
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 80 Seymour St, Hartford, CT 06102
Phone: 860-545-3359    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.